RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases

• প্রধান লেখক: Hajime Honjo (লেখক), Tomohiro Watanabe (লেখক), Ken Kamata (লেখক), Kosuke Minaga (লেখক), Masatoshi Kudo (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Inflammatory bowel diseases (IBDs) are becoming more frequent worldwide. A significant fraction of patients with IBD are refractory to various types of therapeutic biologics and small molecules. Therefore, identification of novel therapeutic targets in IBD is required. Receptor-interacting serine/th...